Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Open Access

Correction

Correction: Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system

  • The PLOS ONE Staff

The funding statement for this paper is incorrect. The publisher apologizes for this error. The correct statement is: The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Small group Research Project under grant number RGP1/136/45.

The following Acknowledgements is missing from the article: The authors extend their appreciation to the Deanship of Research and Graduate Studies at King Khalid University for funding this work through Small Group Research Project under grant number RGP1/136/45.

Reference

  1. 1. Ashar F, Mohammed AAS, Selvamuthukumar S (2024) Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system. PLoS ONE 19(9): e0310492. pmid:39316574

Citation: The PLOS ONE Staff (2024) Correction: Enhancement of oral bioavailability of ibrutinib using a liposil nanohybrid delivery system. PLoS ONE 19(12): e0315777. https://doi.org/10.1371/journal.pone.0315777

Published: December 11, 2024

Copyright: © 2024 The PLOS ONE Staff. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.